| Source NDC Code |
|
Target HCPCS Code |
79952-0110-01
ZYNLONTA 10 MG VIAL
|
⇄
|
C9084
Loncastuximab-lpyl, 0.1 mg
|
| Detail Information |
| Relationship Start Date |
10/01/2021 |
| Relationship End Date |
03/31/2022 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
EA |
|
|
|
79952-0110-01
ZYNLONTA 10 MG VIAL
|
⇄
|
J9359
Inj, loncastuximab tesirine-lpyl, 0.075 mg
|
| Detail Information |
| Relationship Start Date |
04/01/2022 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
EA |
|
|
|
79952-0110-01
ZYNLONTA 10 MG VIAL
|
⇄
|
J9999
NOT OTHERWISE CLASSIFIED, ANTINEOPLASTIC DRUGS
|
| Detail Information |
| Relationship Start Date |
10/01/2021 |
| Relationship End Date |
03/31/2022 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
EA |
|
|
|
79952-0110-01
Zynlonta
|
⇄
|
J9359
Inj lon tesirin-lpyl 0.075mg
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|